🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
120 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 500.0mg (76 products)
Median 500.0mg This product: 200mg

Other Ingredients

Maltodextrin Cellulose Cellulose

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (75% of products) Nutrient (55% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement, take 1 capsule daily.

⚠️ Warnings & Precautions

Disclaimer: Always consult with a qualified health physician before taking any new dietary supplement.

Warning: Keep out of reach of children. Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, or if you have any known or suspected medical conditions, and/or taking prescription drug(s) or OTC medication(s).

Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, or if you have any known or suspected medical conditions, and/or taking prescription drug(s) or OTC medication(s).

🧪 Formulation Notes

Minimum Thymoquinone content: 5%

Additional Information

Storage: Store in a cool and dry place. Keep away from direct sunlight and heat.

Product Details

DSLD Entry Date 2023-05-24
Product Type Botanical
Form Capsule
DSLD ID 285852
Data Updated 2026-04-11

Research Evidence

3 Research Sources
44 Avg Quality Score
2 Clinical Trial
1 Rct
C Effect of a Food Supplement Based on Nigella Sativa Seeds Oil and Vitamin E on Glyco-lipid Parameters in Dysglycemic and Dyslipidemic Perimenopausal Women
Clinical Trial ClinicalTrials.gov 2024
C Nigella Sativa Supplementation in Hyperlipidemia Treatment
Clinical Trial ClinicalTrials.gov 2023
C The possible short-term of Nigella sativa - L in the management of adolescent polycystic ovarian syndrome: results of a randomized controlled trial.
Rct Journal of ovarian research
View all evidence for Black Cumin →

Compare Similar Products

View all Black Cumin products →